Erysipelas risk factors: Difference between revisions
Jump to navigation
Jump to search
Irfan Dotani (talk | contribs) No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Erysipelas}} | {{Erysipelas}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{LRO}} | ||
==Overview== | ==Overview== | ||
==Risk Factors== | ==Risk Factors== | ||
The following risk factors contribute to an individual's predisposition to Erysipelas:<ref name="pmid24884840">{{cite journal |vauthors=Inghammar M, Rasmussen M, Linder A |title=Recurrent erysipelas--risk factors and clinical presentation |journal=BMC Infect. Dis. |volume=14 |issue= |pages=270 |year=2014 |pmid=24884840 |pmc=4033615 |doi=10.1186/1471-2334-14-270 |url=}}</ref><ref name="pmid24884840">{{cite journal |vauthors=Inghammar M, Rasmussen M, Linder A |title=Recurrent erysipelas--risk factors and clinical presentation |journal=BMC Infect. Dis. |volume=14 |issue= |pages=270 |year=2014 |pmid=24884840 |pmc=4033615 |doi=10.1186/1471-2334-14-270 |url=}}</ref> | |||
*[[Immunocompromise]] | |||
*Being [[overweight]] or [[obesity]]<ref name="pmid24884840">{{cite journal |vauthors=Inghammar M, Rasmussen M, Linder A |title=Recurrent erysipelas--risk factors and clinical presentation |journal=BMC Infect. Dis. |volume=14 |issue= |pages=270 |year=2014 |pmid=24884840 |pmc=4033615 |doi=10.1186/1471-2334-14-270 |url=}}</ref> | |||
*Experiencing a disruption of the [[cutaneous]] barrier | |||
*[[Venous insufficiency]] | |||
*[[Lymphedema]]<ref name="pmid10364117">{{cite journal |vauthors=Dupuy A, Benchikhi H, Roujeau JC, Bernard P, Vaillant L, Chosidow O, Sassolas B, Guillaume JC, Grob JJ, Bastuji-Garin S |title=Risk factors for erysipelas of the leg (cellulitis): case-control study |journal=BMJ |volume=318 |issue=7198 |pages=1591–4 |year=1999 |pmid=10364117 |pmc=28138 |doi= |url=}}</ref> | |||
*History of [[mastectomy]]<ref name="pmid1364813">{{cite journal |vauthors=Simon MS, Cody RL |title=Cellulitis after axillary lymph node dissection for carcinoma of the breast |journal=Am. J. Med. |volume=93 |issue=5 |pages=543–8 |year=1992 |pmid=1364813 |doi= |url=}}</ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 19:53, 12 September 2016
|
Erysipelas Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Erysipelas risk factors On the Web |
|
American Roentgen Ray Society Images of Erysipelas risk factors |
|
Risk calculators and risk factors for Erysipelas risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S.
Overview
Risk Factors
The following risk factors contribute to an individual's predisposition to Erysipelas:[1][1]
- Immunocompromise
- Being overweight or obesity[1]
- Experiencing a disruption of the cutaneous barrier
- Venous insufficiency
- Lymphedema[2]
- History of mastectomy[3]
References
- ↑ 1.0 1.1 1.2 Inghammar M, Rasmussen M, Linder A (2014). "Recurrent erysipelas--risk factors and clinical presentation". BMC Infect. Dis. 14: 270. doi:10.1186/1471-2334-14-270. PMC 4033615. PMID 24884840.
- ↑ Dupuy A, Benchikhi H, Roujeau JC, Bernard P, Vaillant L, Chosidow O, Sassolas B, Guillaume JC, Grob JJ, Bastuji-Garin S (1999). "Risk factors for erysipelas of the leg (cellulitis): case-control study". BMJ. 318 (7198): 1591–4. PMC 28138. PMID 10364117.
- ↑ Simon MS, Cody RL (1992). "Cellulitis after axillary lymph node dissection for carcinoma of the breast". Am. J. Med. 93 (5): 543–8. PMID 1364813.